| Betaferon/Betaseron |
All Financial Data in US $ (mln) |
| Word Search (Top 10 - by date) |
Bayer Increases Sales and Earnings in the Second Quarter
Bayer
(July 29, 2010)
|
Novartis Delivers Strong Financial Performance in Second Quarter, Underpinned by Increased Momentum in Innovation
Novartis
(July 15, 2010)
|
Study Supports Long-Term Safety Profile of Betaferon® for Multiple Sclerosis Over 16 Years
Bayer
(June 08, 2010)
|
Bayer HealthCare Launches First iPhone Application with Personalized Tools to Assist People on Betaseron® (interferon beta-1b) in Managing Their Multiple Sclerosis Treatment
Bayer
(June 03, 2010)
|
Interim Results For The Six Months Ended 31 March 2010
GW Pharmaceuticals
(May 20, 2010)
|
Interim Report for the First Quarter of 2010
Bayer
(April 29, 2010)
|
Novartis Healthcare Portfolio Generates Strong Growth in First Quarter of 2010, Progress on Delivering Innovation, Growth and Productivity
Novartis
(April 20, 2010)
|
Bayer Successful in a Difficult Environment
Bayer
(February 26, 2010)
|
Acorda Therapeutics Announces Adrian L. Rabinowicz Joins as Senior Vice President of Medical Affairs
Acorda Therapeutics
(February 22, 2010)
|
Novartis Achieves Record Results in 2009 as Momentum from Recently Launched Products Drives Growth Across Its Entire Healthcare Portfolio
Novartis
(January 26, 2010)
|
|
|
|
|
EvaluatePharma® - the premier source for pharma and biotech analysis.
Expert integration of financial and product data across historic and forecast timeframes (1986 to 2016) delivers a vast array of analytics by product, company, therapy area, EphMRA ATC code, technology, patent status (expiry date/ number), deals (upfront/ milestones), license revenues (royalties/ co-promotion) and much more.
|
| Summary Product Name Information |
|
|
| Product Sales Summary 2007/08 |
|
Annual Sales WW - Sales
|
Growth per Year (%)
|
|
Rank1 |
Generic Name
|
Therapeutic Subcategory
|
2007 |
2008
|
2008 |
| Betaferon/Betaseron2 |
|
|
|
1,410 |
1,681 |
|
+19% |
|
|
Note: Shaded Cells3 |
|
|
More Product Information for EvaluatePharma® subscribersSubscribers see:
- Sales (historic and forecast to 2016 where available) listed by the reporting company or companies, including royalty, license and JV revenue where applicable
- Details of all events impacting the product
- Detailed product information, including sales forecasts listed by the reporting company or companies, indications (approved and in trial)
|
Register to access more FREE content:
- 2009 Product Sales analysis
- Download analysis into Excel
- Search 2 yrs of company press releases
| Research Codes Synonyms |
|
|
| Product: |
Betaferon/Betaseron |
|
|
|
|
|